Divya Pushkarna, B.Tech

Director of Evidence Synthesis
Evidinno Outcomes Research Inc, Canada

Poster(s):

• (41) Olezarsen and plozasiran in the treatment of familial chylomicronemia syndrome (FCS): Results from a matching-adjusted indirect comparison (MAIC)
  Wednesday, October 29, 2025